Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 2/12/2020
SIETES contiene 93176 citas

 
 
 1 a 6 de 6 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Olanow CW, Rascol O. Rasagiline in Parkinson's disease. The authors reply. N Engl J Med 2010;362:658-9. [Ref.ID 87903]
2.Tiene citas relacionadas Cita con resumen
Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E, for the ADAGIO Study Investigators. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med 2009;361:1268-78. [Ref.ID 86821]
3.
Schapira AHV, Olanow CW. Neuroprotection in Parkinson disease. Mysteries, myths, and misconceptions. JAMA 2004;291:358-64. [Ref.ID 68759]
4.Tiene citas relacionadas
Olanow CW, Freeman T, Kordower J. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;345:146. [Ref.ID 57467]
5.Tiene citas relacionadas
Freeman TB, Vawter DE, Olanow CW. Placebo surgery in trials of therapy for Parkinson's disease. N Engl J Med 2000;342:354-5. [Ref.ID 49259]
6.Tiene citas relacionadas
Freeman TB, Vawter DE, Leaverton PE, Godbold JH, Hauser RA, Goetz CG, Olanow CW. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med 1999;341:988-91. [Ref.ID 47065]
Seleccionar todas
 
 1 a 6 de 6